The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases
Tao Yu(Shanghai Jiao Tong University), Jae Youl Cho(Sungkyunkwan University), Yanyan Yang(Wannan Medical College), Hong Xu(Qingdao University), Eunji Kim(Korea University), Zhibin Wang(Northwest A&F University), Yan Liu(Capital Medical University), Bing Li(Xijing Hospital), Min Li(Qingdao University), Wang Jie(Haier Group (China)), Xiuxiu Fu(Qingdao University)
Cited by 61
Related Papers
Lactate metabolism in human health and disease
|Signal Transduction and Targeted Therapy|2022|1.4k
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963
CRISPR/Cas9 therapeutics: progress and prospects
|Signal Transduction and Targeted Therapy|2023|706
Skin Protective Effect of Epigallocatechin Gallate
|International Journal of Molecular Sciences|2018|164
Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities
|Scientific Reports|2017|156